Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

Indicate Solutions

Indicate Solutions_logo
21
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Indicate Solutions is working on a novel platform nucleic acid detection technology based on nanoparticles to identify coronavirus in the saliba of infected patients rapidly (<30 mins) in a easy-to-use solution kit format to be used wherever needed.

Donostia-San Sebastián, Gipuzkoa, Spain

Send a message

  • 3

    employees

  • €0

    turnover

Anglais

Indicate Solutions

Anglais

Indicate Solutions, S.L. was set up in 2016 to exploit and commercialise the IP generated by the INDICATE (IN vitro DIagnostic CAncer TEst) project. The concept behind the INDICATE project was simple; to create a rapid nucleic acid test (NAT) as a single-use handheld POC device, similar in format and cost to pregnancy tests but used to detect actionable mutations of patients.

 

In...

See more

Indicate Solutions, S.L. was set up in 2016 to exploit and commercialise the IP generated by the INDICATE (IN vitro DIagnostic CAncer TEst) project. The concept behind the INDICATE project was simple; to create a rapid nucleic acid test (NAT) as a single-use handheld POC device, similar in format and cost to pregnancy tests but used to detect actionable mutations of patients.

 

In other words, our objective is to be the ClearBlue™ of diagnostics. 

 

The INDICATE project  was originally conceived in 2013 by Charles Lawrie of Biodonostia, and Luis Liz-Marzán and Marek Gzelczak of CIC biomaGUNE in Donostia-San Sebastián, Spain. 

Indicate Solutions is dedicated to developing handheld economic single use rapid nucleic acid tests (NAT) in order to revolutionise current diagnostic practices. Imagine a scenario where patients can monitor their response to treatments and the progress of their diseases in the comfort of their own home, or at the pharmacy or in their local doctors surgery. Imagine being able to diagnose SARS-CoV-2, HIV or Ebola immediately just using Saliva and wherever and whenever you need, without the need for electricity or other infrastructure.

 

In response to the global COVID-19 crisis, Indicate Solutions has conceived a Sars2 rapid test called REPViT. 

 

Tests is based on the same principles as the pregnancy test for which Indicate Solutions is now seeking funding to advance development to a pre-commercialisation stage.

  • 1

    Like

Our latest news

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
183 Entities

Communities

Access2EIC – Seal of Excellence
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors. https://access2eic.eu/
1931 Members
InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
1290 Members

Our history

Start in Begining of the Story

  • Begining of the Story

    Indicate Solutions was formed in 2016 to commercialise the Intellectual Property (IP) generated.

  • We were granted with the IP

    Indicate Solutions has an exclusive licence to commercialise the IP of the patent.

  • Filled new EPO Patent

    In response to COVID-19 crisis, Indicate has conceived a Sars2 rapid test. Filled EPO patent.

to be continued ...